|Application ||WB, IF|
|Calculated MW||11175 Da|
|Other Names||Apolipoprotein A-II, Apo-AII, ApoA-II, Apolipoprotein A2, Proapolipoprotein A-II, ProapoA-II, Truncated apolipoprotein A-II, Apolipoprotein A-II(1-76), APOA2|
|Target/Specificity||A synthetic peptide corresponding to residues in human Apolipoprotein A-II (ApoA-II) was used as an immunogen.|
|Format||50 mM Tris-Glycine (pH 7.4), 0.15 M NaCl, 40% Glycerol, 0.01% sodium azide and 0.05% BSA.|
|Storage||Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.|
|Precautions||Apolipoprotein A-II (ApoA-II) Antibody is for research use only and not for use in diagnostic or therapeutic procedures.|
|Function||May stabilize HDL (high density lipoprotein) structure by its association with lipids, and affect the HDL metabolism.|
|Tissue Location||Plasma; synthesized in the liver and intestine|
email@example.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Apolipoprotein A II is the second most abundant protein of the high density lipoprotein particles, accounting for 20% of protein mass of HDL. The concentration of ApoA-I and ApoA-II is inversely correlated with the frequency of heart disease in human (1). In studies with mice and humans, ApoA-II levels have been associated with increased susceptibility to atherosclerosis, increased free fatty acid levels, increased body fat, and increased insulin resistance (2). ApoA-II consists of three potential amphipathic helices of 17 residues each, which contribute to the lipid-binding properties of this apolipoprotein (3). Currently, the best characterized activity of apoA-II is its potent antagonism of the anti-atherogenic and anti-inflammatory activities of ApoA-I, probably due to its competition with the latter for lipid acyl side chains of HDL (1).
1. Kumar et al. Biochemistry. 41 (39):11681-11691, 2002 2. Castellani and Lusis. Arterioscler. Thromb. Vasc. Biol. 21:1870-1872, 2001 3. Benetollo et al. Eur. J. Biochem. 242 :657-664, 1996
If you have any additional inquiries please email technical services at firstname.lastname@example.org.